Risk Scores & Tools for Predicting Cardiovascular Risk in Asymptomatic Individuals
Risk Scores & Tools for Predicting Cardiovascular Risk in Asymptomatic Individuals ;
These tools are designed to estimate the future risk of cardiovascular events—such as myocardial infarction or stroke—over a specific period (usually 10 years or lifetime). They are preventive in nature and do not require symptoms. Based on clinical and/or imaging markers, they support decision-making in lifestyle changes and primary prevention strategies (e.g., statins).
Here is a summary of the most relevant and widely used risk assessment tools in asymptomatic individuals:
1. SCORE2 / SCORE2-OP (Europe – ESC)
• Target: Adults aged 40–69 (SCORE2), and ≥70 (SCORE2-OP)
• Purpose: 10-year risk of first fatal and non-fatal CVD event
• Ideal for: General European population
• Link:
https://www.escardio.org/Education/ESC-Scientific-Document-Library/SCORE2-new-CVD-risk-assessment-in-Europe
2. ASCVD Risk Estimator Plus (USA – ACC/AHA)
• Target: Adults aged 40–79 without known ASCVD
• Purpose: Estimates both 10-year and lifetime ASCVD risk
• Link:
https://tools.acc.org/ASCVD-Risk-Estimator-Plus
3. QRISK3 (UK – NHS)
• Target: Adults aged 25–84 without CVD
• Purpose: 10-year risk of MI or stroke
• Link:
https://www.qrisk.org/three/
4. Framingham Risk Score (USA – NHLBI)
• Target: Adults aged 30–74 without prior CVD
• Purpose: 10-year CHD/CVD risk estimate
• Link:
https://www.mdcalc.com/calc/61/framingham-risk-score-hard-coronary-heart-disease
5. Reynolds Risk Score (USA – Harvard)
• Target: Men ≥50, Women ≥45, healthy individuals
• Purpose: 10-year CVD risk (adds hs-CRP & family history)
• Link:
https://www.reynoldsriskscore.org/
6. MESA Risk Score (USA – MESA Study)
• Target: Asymptomatic adults with intermediate risk
• Purpose: 10-year CHD risk (includes CAC score)
• Link:
https://www.mesanhlbi.org/MESACHDRisk/MesaRiskScore/RiskScore.aspx
7. CAC Score (Agatston Score)
• Type: Imaging-based only (coronary CT)
• Use: Stratify statin decisions based on CAC value
• Endorsed by: 2018 AHA/ACC and 2021 AHA
• Link:
https://www.ahajournals.org/doi/10.1161/CIR.0000000000000946
